A new unified measure for evaluation of randomized response techniques. [PDF]
Azeem M, Salam A, Albalawi O, Hussain S.
europepmc +1 more source
ABSTRACT Objective To compare the effectiveness and safety of tenecteplase (TNK) versus alteplase (TPA) in patients with basilar artery occlusion prior to endovascular treatment (EVT). Methods In this retrospective multicenter study (BAO‐TNK), we analyzed consecutive BAO patients from 14 U.S.
Rahul R. Karamchandani +38 more
wiley +1 more source
Network Localization of Fatigue in Multiple Sclerosis
ABSTRACT Background Fatigue is among the most common symptoms and one of the main factors determining the quality of life in multiple sclerosis (MS). However, the neurobiological mechanisms underlying fatigue are not fully understood. Here we studied lesion locations and their connections in individuals with MS, aiming to identify brain networks ...
Olli Likitalo +12 more
wiley +1 more source
More is not always better: An experimental individual-level validation of the randomized response technique and the crosswise model. [PDF]
Höglinger M, Jann B.
europepmc +1 more source
Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin +2 more
wiley +1 more source
Use of generalized randomized response model for enhancement of finite population variance: A simulation approach. [PDF]
Shabbir J, Movaheedi Z.
europepmc +1 more source
Understanding the drivers of sensitive behavior using Poisson regression from quantitative randomized response technique data. [PDF]
Cao M +4 more
europepmc +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
Modeling Evasive Response Bias in Randomized Response: Cheater Detection Versus Self-protective No-Saying. [PDF]
Sayed KHA +2 more
europepmc +1 more source
Asking Sensitive Questions Using the Randomized Response Approach in Public Health Research: An Empirical Study on the Factors of Illegal Waste Disposal. [PDF]
Chong ACY, Chu AMY, So MKP, Chung RSW.
europepmc +1 more source

